A 7-day decitabine included conditioning regimen accelerated donor hematopoietic engraftment while reduced the occurrence of mucositis without interfering with prognosis.

Yuan Yuan Shi,Long Su,Zeng Yan Liu,Yi Geng Cao,Xin Chen,Rong Li Zhang,Qing Zhen Liu,Jian Feng Yao,Wei Hua Zhai,Qiao Ling Ma,Er Lie Jiang,Ming Zhe Han

Chemotherapy（2023）

引用 0|浏览14

暂无评分

摘要

These results demonstrated that this 7-day decitabine contained new conditioning regimen seems to be feasible and safe for patients with myeloid neoplasms who receive allo-HSCT, and a large-scale prospective study is needed to confirm the findings of this study.

查看译文

关键词

mucositis,donor,decitabine-included

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要